Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Fate Therapeutics)"
Count: 15
Selected: 0
NCT IDTitle
NCT04629729FT819 in Subjects With B-cell Malignancies
NCT04614636FT538 in Subjects With Advanced Hematologic Malignancies
NCT04551885FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
NCT04245722FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies
NCT04106167Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
NCT04093622Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
NCT04023071FT516 in Subjects With Advanced Hematologic Malignancies
NCT03841110FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
NCT03319459FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
NCT02743351Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
NCT02354443A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders
NCT02354417A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies
NCT01627314The PUMA Trial is a Trial of a Single ProHema Modulated-CB Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.
NCT01527838Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit
NCT00890500Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.